The data for subgroups with only one elevated BGL are unpublished. To estimate these, HAPO data for macrosomia (birth weight .90th centile) were evaluated [see Table 2 in Metzger et al. (2) ] using the IADPSG stepwise approach (1) . There were 23,217 subjects and 2,221 cases of macrosomia (prevalence 9.6%). The number having GDM (fasting blood glucose [FBG] $5.1 mmol/L) was 1,927 (8.3%). This should comprise all cases in FBG categories 7 (217) and 6 (672) and a proportion from category 5 (1,038 of 1,883). In those with GDM, the calculated number of pregnancies with macrosomia was 352, with a risk ratio (RR) of 0.223. This stepwise exploratory analysis of the effect of known normal BGLs on risk demonstrates progressive decreases in the prevalence of macrosomia and RRs of GDM pregnancies having macrosomia compared with expected rates (FBG rates derived from the whole cohort).
The statistical power underpinning IADPSG thresholds may be significantly reduced in subgroups having one elevated BGL only. If confirmed, it suggests the IADPSG thresholds may not apply to these subgroups and that higher thresholds should apply. These subgroups represent the majority (;70%) identified by the IADPSG criteria. Potentially ,50% of them may have a risk exceeding the specified odds ratio of 1.75. In other words, two normal BGL parameters may be protective. However, the IADPSG criteria correctly identify at-risk subjects with three elevated BGL parameters, suggesting that no single BGL adequately defines risk and that all three BGL parameters should be assessed together.
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